Product Images Vesicare LS
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Vesicare LS NDC 51248-250 by Astellas Pharma Us, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
structure of Solifenacin succinate - image 01
VESIcare LS (solifenacin succinate) Oral Suspension 5 mg/5 mL (1 mg/mL) carton label - image 02
VESIcare LS (solifenacin succinate) Oral Suspension 5 mg/5 mL (1 mg/mL) bottle label - image 03
Each 1 mL of an oral suspension medication contains solifenacin succinate. The medication should be protected from light and dispensed in a light-resistant container by a pharmacist. The recommended storage temperature is between 15°C to 30°C (55 to 86°F) according to USP Controlled Room Oral Suspension guidelines, and the medication can be used for 28 days after the first opening. The medication is produced in Ireland and should be shaken well before use. The strength of the suspension is 1mg/mL.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.